Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,01 AUD | -.--% |
|
-.--% | -.--% |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Development
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -92,24 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -92,24 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 52 | 05/01/23 | |
Director of Finance/CFO | 62 | 01/07/23 | |
Chief Tech/Sci/R&D Officer | - | 01/07/23 | |
Julie Kerner
COO | Chief Operating Officer | - | 01/07/23 |
Liz Doolin
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/08 |
Adrian Hinton
AUD | Comptroller/Controller/Auditor | 72 | 01/05/19 |
Rajeev Chandra
SEC | Corporate Secretary | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Wilson
BRD | Director/Board Member | 61 | 16/06/16 |
Alan Fisher
CHM | Chairman | 71 | 01/09/16 |
Jane Ryan
BRD | Director/Board Member | 65 | 01/10/20 |
Aaron Weaver
BRD | Director/Board Member | 43 | 06/07/20 |
Chief Executive Officer | 52 | 05/01/23 | |
Peter Davies
BRD | Director/Board Member | 43 | 01/07/21 |
Información de la empresa
![Dirección Bionomics(BNO)](https://cdn.zonebourse.com/static/address/7136133.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,03 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción BNOX
- Acción BNO
- Empresa Bionomics